INdividualized ITI Based on Fviii(ATE) Protection by VWF (INITIATE)
Phase of Trial: Phase IV
Latest Information Update: 02 May 2019
Price : $35 *
At a glance
- Drugs Factor VIII/von Willebrand factor (Primary)
- Indications Haemophilia A
- Focus Therapeutic Use
- Acronyms INITIATE
- 04 Dec 2018 Results presented at the 60th Annual Meeting and Exposition of the American Society of Hematology.
- 31 Aug 2018 Biomarkers information updated
- 26 Jul 2017 Status changed from active, no longer recruiting to recruiting.